Is Ares Capital (ARCC) a Buy as Wall Street Analysts Look Optimistic?

Ares Capital (ARCC) currently holds an Average Brokerage Recommendation (ABR) of 1.53, signifying a 'Strong Buy' to 'Buy' consensus from 15 brokerage firms. However, the article cautions against relying solely on this optimistic ABR, highlighting a 0.1% decline in the Zacks Consensus Estimate for ARCC's current year earnings per share to $2.01 over the past month, which has resulted in a Zacks Rank #4 (Sell). This divergence suggests that the positive analyst sentiment for ARCC should be viewed with skepticism, given the negative trend in earnings estimate revisions and potential near-term stock price pressure.

Analysis

Ares Capital (ARCC) currently exhibits a conflicting set of signals for investors. The Average Brokerage Recommendation (ABR) for ARCC stands at an optimistic 1.53, approximating between 'Strong Buy' and 'Buy' based on 15 brokerage firms, with 10 of these recommendations being 'Strong Buy' (66.7%). This suggests a generally positive sentiment from sell-side analysts.

However, this positive ABR is contradicted by recent earnings estimate revisions. The Zacks Consensus Estimate for ARCC's current year earnings per share has declined by 0.1% over the past month to $2.01. This downward revision, indicating growing pessimism among analysts regarding the company's earnings prospects, has led to a Zacks Rank #4 (Sell) for ARCC.

The article highlights that brokerage recommendations often carry a strong positive bias due to vested interests, making them less reliable for predicting near-term stock price movements compared to earnings estimate revisions. The timeliness and empirical correlation of earnings estimate revisions with future stock prices suggest that the declining EPS estimates for ARCC are a more pertinent indicator of potential near-term stock price pressure.

This divergence underscores the importance of scrutinizing traditional brokerage ratings. The article implicitly advises investors to use such recommendations as validation rather than primary drivers for investment decisions, especially when quantitative models like the Zacks Rank, based on earnings estimate revisions, signal a different outlook.

Key Decisions for Investors

• Investors should exercise caution regarding Ares Capital (ARCC) despite its favorable Average Brokerage Recommendation (ABR) of 1.53, given the recent 0.1% decline in its Zacks Consensus EPS estimate to $2.01 and its subsequent Zacks Rank #4 (Sell).
• It is prudent to prioritize the negative trend in earnings estimate revisions over the potentially biased brokerage recommendations, as these revisions are empirically shown to correlate more strongly with near-term stock price movements.
• Consider validating all brokerage recommendations with independent fundamental analysis or quantitative models, and closely monitor ARCC's earnings prospects for any further revisions that could impact its near-term stock performance.